Intravenous immunoglobulin: recent advances in the treatment of autoimmune bullous diseases.
Autoimmune bullous diseases describes a heterogenous group of diseases with skin and mucosal involvement with varying degrees of mortality. Intravenous immunoglobulin (IVIg) is a specialised treatment used in the management of these AIBD with variable success. This paper outlines the use of IVIg in these diseases.
Department of Dermatology, St George Hospital, Sydney, NSW, Australia.
B S
BS
Daniel
D F
DF
Murrell
D001327:Autoimmune Diseases / Q000188:drug therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D010391:Pemphigoid, Bullous / Q000188:drug therapy*
D016756:Immunoglobulins, Intravenous